Terumo's revenue share FY 2020, by business segment
In the fiscal year 2020, the cardiac and vascular company generated around 54 percent of the consolidated revenue of Terumo Corporation. Terumo's cardiac and vascular segment mainly manufactures products such as angiographic guidewires, introducer sheaths, hydrogel embolic coils, and surgical grafts. That year, the total revenue of the corporation amounted to approximately 614 billion Japanese yen. Founded in 1921, Terumo is one of the major medical device manufacturers headquartered in Tokyo Prefecture, Japan.
